FBL Financial Group Reports Second Quarter 2017 Results
Financial Highlights
(Dollars in thousands, except per share data)
Three months ended |
|||||||
2017 | 2016 | ||||||
Net income attributable to |
$ | 32,291 | $ | 24,380 | |||
Operating income(1) | 30,817 | 25,676 | |||||
Earnings per common share (assuming dilution): | |||||||
Net income | 1.29 | 0.97 | |||||
Operating income(1) | 1.23 | 1.02 | |||||
- A growing book of profitable business
- The benefit of other investment-related income of
$0.07 per share - Mortality results better than expectations
Operating income differs from the GAAP measure, net income attributable to
"
Product Revenues. Premiums and product charges for the second quarter of 2017 totaled
Investment Income. Net investment income in the second quarter of 2017 totaled
Benefits and Expenses. Benefits and expenses totaled
Net Realized Gains/Losses on Investments. In the second quarter of 2017,
Stock Repurchases. During the second quarter of 2017,
Capital and Book Value. As of
Further Financial Information. Further information on
Conference Call.
Certain statements in this release concerning
|
||||||||||||||||
Consolidated Statements of Operations (Unaudited) |
||||||||||||||||
(Dollars in thousands, except per share data) |
||||||||||||||||
Three months ended | Six months ended | |||||||||||||||
|
|
|||||||||||||||
2017 | 2016 | 2017 | 2016 | |||||||||||||
Revenues: | ||||||||||||||||
Interest sensitive product charges | $ | 29,456 | $ | 29,027 | $ | 58,657 | $ | 57,138 | ||||||||
Traditional life insurance premiums | 50,262 | 49,605 | 98,696 | 99,743 | ||||||||||||
Net investment income | 103,908 | 100,722 | 204,902 | 199,107 | ||||||||||||
Net realized capital gains (losses) on sales of investments | 921 | (2,269 | ) | 518 | (679 | ) | ||||||||||
Total other-than-temporary impairment losses | — | (25 | ) | (66 | ) | (3,744 | ) | |||||||||
Non-credit portion in other comprehensive income | — | — | — | 1,522 | ||||||||||||
Net impairment losses recognized in earnings | — | (25 | ) | (66 | ) | (2,222 | ) | |||||||||
Other income | 4,450 | 4,225 | 8,210 | 7,864 | ||||||||||||
Total revenues | 188,997 | 181,285 | 370,917 | 360,951 | ||||||||||||
Benefits and expenses: | ||||||||||||||||
Interest sensitive product benefits | 58,251 | 58,559 | 121,011 | 112,978 | ||||||||||||
Traditional life insurance benefits | 42,610 | 43,369 | 85,564 | 87,938 | ||||||||||||
Policyholder dividends | 2,557 | 2,515 | 5,110 | 5,555 | ||||||||||||
Underwriting, acquisition and insurance expenses | 36,341 | 38,938 | 70,694 | 76,652 | ||||||||||||
Interest expense | 1,213 | 1,213 | 2,425 | 2,425 | ||||||||||||
Other expenses | 4,740 | 4,435 | 8,891 | 8,793 | ||||||||||||
Total benefits and expenses | 145,712 | 149,029 | 293,695 | 294,341 | ||||||||||||
43,285 | 32,256 | 77,222 | 66,610 | |||||||||||||
Income taxes | (13,891 | ) | (10,477 | ) | (24,624 | ) | (21,546 | ) | ||||||||
Equity income, net of related income taxes | 2,924 | 2,613 | 6,155 | 5,265 | ||||||||||||
Net income | 32,318 | 24,392 | 58,753 | 50,329 | ||||||||||||
Net income attributable to noncontrolling interest | (27 | ) | (12 | ) | (29 | ) | (3 | ) | ||||||||
Net income attributable to |
$ | 32,291 | $ | 24,380 | $ | 58,724 | $ | 50,326 | ||||||||
Earnings per common share - assuming dilution | $ | 1.29 | $ | 0.97 | $ | 2.34 | $ | 2.01 | ||||||||
Weighted average common shares | 25,031,312 | 24,987,878 | 25,033,307 | 24,969,727 | ||||||||||||
Effect of dilutive securities | 19,663 | 42,566 | 20,777 | 50,358 | ||||||||||||
Weighted average common shares - diluted | 25,050,975 | 25,030,444 | 25,054,084 | 25,020,085 | ||||||||||||
(1) Reconciliation of Net Income Attributable to
In addition to net income,
Three months ended | Six months ended | ||||||||||||||
|
|
||||||||||||||
2017 | 2016 | 2017 | 2016 | ||||||||||||
(Dollars in thousands, | |||||||||||||||
except per share data) | |||||||||||||||
Net income attributable to |
$ | 32,291 | $ | 24,380 | $ | 58,724 | $ | 50,326 | |||||||
Adjustments: | |||||||||||||||
Net realized gains/losses on investments (a) | (788 | ) | 1,147 | (234 | ) | 1,544 | |||||||||
Change in net unrealized gains/losses on derivatives (a) | (686 | ) | 149 | (685 | ) | 124 | |||||||||
Operating income | $ | 30,817 | $ | 25,676 | $ | 57,805 | $ | 51,994 | |||||||
Operating income per common share - assuming dilution | $ | 1.23 | $ | 1.02 | $ | 2.30 | $ | 2.08 | |||||||
(a) Net of adjustments, as applicable, to amortization of unearned revenue reserves, deferred acquisition costs, value of insurance in force acquired, interest sensitive policy reserves and income taxes attributable to these items.
In the fourth quarter of 2016, due to changes in product offerings since the last amendment to its policy for calculating operating income,
(2) Premiums Collected - Net statutory premiums collected is a non-GAAP measure and includes premiums collected from annuities and universal life-type products. It is a useful metric for investors as it is a measure of sales production. For GAAP reporting, these premiums received are not reported as revenues.
(3) Reconciliation of Book Value Per Share Excluding Accumulated Other Comprehensive Income - Unaudited
|
|
||||||
2017 | 2016 | ||||||
Book value per share | $ | 50.05 | $ | 47.61 | |||
Less: Per share impact of accumulated other comprehensive income | 8.51 | 6.01 | |||||
Book value per share, excluding accumulated other comprehensive income | $ | 41.54 | $ | 41.60 | |||
Book value per share excluding accumulated other comprehensive income is a non-GAAP financial measure. Accumulated other comprehensive income totaled
|
|||||||
Condensed Consolidated Balance Sheets (Unaudited) |
|||||||
(Dollars in thousands) |
|||||||
|
|
||||||
2017 | 2016 | ||||||
Assets | |||||||
Investments | $ | 8,454,903 | $ | 8,174,660 | |||
Cash and cash equivalents | 43,809 | 33,583 | |||||
Deferred acquisition costs | 296,637 | 330,324 | |||||
Other assets | 421,668 | 430,495 | |||||
Assets held in separate accounts | 625,971 | 597,072 | |||||
Total assets | $ | 9,842,988 | $ | 9,566,134 | |||
Liabilities and stockholders' equity | |||||||
Liabilities | |||||||
Future policy benefits | $ | 6,898,925 | $ | 6,799,417 | |||
Other policy funds, claims and benefits | 634,361 | 638,848 | |||||
Debt | 97,000 | 97,000 | |||||
Other liabilities | 335,862 | 245,539 | |||||
Liabilities related to separate accounts | 625,971 | 597,072 | |||||
Total liabilities | 8,592,119 | 8,377,876 | |||||
Stockholders' equity | |||||||
|
|||||||
Preferred stock | 3,000 | 3,000 | |||||
Class A common stock | 153,343 | 152,903 | |||||
Class B common stock | 72 | 72 | |||||
Accumulated other comprehensive income | 212,357 | 149,555 | |||||
Retained earnings | 882,012 | 882,672 | |||||
|
1,250,784 | 1,188,202 | |||||
Noncontrolling interest | 85 | 56 | |||||
Total stockholders' equity | 1,250,869 | 1,188,258 | |||||
Total liabilities and stockholders' equity | $ | 9,842,988 | $ | 9,566,134 | |||
Common shares outstanding | 24,928,568 | 24,893,955 |
View source version on businesswire.com: http://www.businesswire.com/news/home/20170803006061/en/
V.P. Corporate & Investor Relations
[email protected]
Source:
Studies from Sorbonne University in the Area of HIV/AIDS Described (Men from Sub-Saharan Africa Living in Worker Hostels in France: A Hidden…
Researchers from Tabriz University of Medical Sciences Report Recent Findings in Health Insurance (Systematic Review of Willingness to Pay for Health…
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News